State of the World from NPR - What It’s Like to Cover the War Between Israel and Hamas
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
my private podcast channel
Back on track with inventory, Target plans its next phase of growth with an industry mandate: the membership program.
(00:21) Ron Gross and Jason Moser discuss:
- Crowdstrike’s eye-popping quarter and the strength of cybersecurity spend.
- Target’s rebound and how it might get back to growth.
- The stories behind rough earnings from Foot Locker, Campbell’s, and Nordstrom.
(19:11) Motley Fool Money’s go-to film critic Nell Minow provides an Oscars preview, update on the state of the movie biz and some of her favorite films from 2023.
(34:41) Ron and Jason break down two stocks on their radar: UiPath and Titan.
Stocks discussed: CRWD, TGT, TWLO, FL, CPB, JWN, TWI, PATH
Host: Dylan Lewis
Guests: Ron Gross, Jason Moser, Nell Minow
Engineers: Dan Boyd
Learn more about your ad choices. Visit megaphone.fm/adchoices
CrowdScience listener Gregory wants to know what affects the way we see the colours of the world. He was looking at a blue summer sky with a friend and they got to wondering whether they both see the same colour blue. So what does influence our vision of the colours that surround us? Could eye colour have anything to do with it? And can we ever really know if your blue sky is the same as mine?
Caroline Steel comes up with some answers, talking to colour scientists about their research into the multiple factors that enable us to see in multi colours, from the intricate biology of our eye to the changing environment around us.
She also investigates her own colour vision and solves a personal mystery, discovering why the world has always looked a slightly different colour from each eye.
Contributors: Professor Jay Neitz, Department of Opthalmology, University of Washington, US Professor Hannah Smithson, Department of Experimental Psychology, University of Oxford Dr Juan Perea García, researcher, Department of Cognitive Psychology, University of Leiden Dr Lauren Welbourne, researcher, Department of Psychology, University of York Dr Adam Bibbey, lecturer in sport, Department of Sport, Oxford Brookes University
Presenter: Caroline Steel Producer: Jo Glanville Editor: Cathy Edwards Production co-ordinator: Connor Morgans Studio manager: Jackie Margerum
(Photo: LWA)
Ranjan Roy from Margins is back for our weekly discussion of the latest tech news. We cover 1) OpenAI's leadership in flux as Mira Murati named in NYTimes report about Sam Altman's ouster 2) Where's Ilya Sutskever? 3) OpenAI reveals that open source was never so important in Musk lawsuit rebuttal 4) The AI field is wide open now! 5) Anthropic's new bot realized it was being tested 6) Is AI close to sentience? 7) Apple sales drop 24% in China as Huawei surges 8) Apple fined 1.9 billion euro for anti-competitive moves in the music space 9) Apple's reputational risk 10) Apple revokes and reinstates Epic Games' developer license 11) Apple's AI play 12) Could the TikTok ban be for real this time? 13) TikTok's risky political strategy 14) Rise of China in the App Store 15) Temu's strange math 16) Bitcoin hits $70,000
---
Enjoying Big Technology Podcast? Please rate us five stars ⭐⭐⭐⭐⭐ in your podcast app of choice.
Want a discount for Big Technology Premium? Here’s 40% off for the first year: https://tinyurl.com/bigtechnology
Questions? Feedback? Write to: bigtechnologypodcast@gmail.com
CoinDesk Indices presents notable data insights from the week, followed by additional analysis from an industry expert.
To get the show every day, follow the podcast here.
The CoinDesk Market Index (CMI) functions as a benchmark for the performance of the digital asset market, delivering institutional quality information to digital asset investors. Subsets of the CoinDesk Market Index (CMI) are investible CoinDesk Crypto Sectors and the CoinDesk 20 Index, designed to measure the performance of the top digital assets. Today’s takeaways are provided by Tracy Stephens, senior index manager at CoinDesk Indices with additional analysis from Greg Magadini, director of derivatives at Amberdata. For more on CoinDesk Indices, visit: coindeskmarkets.com.
-
Consensus is where experts convene to talk about the ideas shaping our digital future. Join developers, investors, founders, brands, policymakers and more in Austin, Texas from May 29-31. The tenth annual Consensus is curated by CoinDesk to feature the industry’s most sought-after speakers, unparalleled networking opportunities and unforgettable experiences. Take 15% off registration with the code MD15. Register now at consensus.coindesk.com.
-
This episode was hosted by Jennifer Sanasie and uses Wondercraft AI Voice. “Markets Daily” is executive produced by Jared Schwartz and produced and edited by Eleanor Pahl, alongside Senior Booking Producer Melissa Montañez. All original music by Doc Blust and Colin Mealey.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Eric Balchunas of Bloomberg Intelligence explains why the spot Bitcoin ETFs have made TradFi move at the speed of crypto — and why he’s uncertain spot Ether ETFs will be approved.
Listen to the episode on Apple Podcasts, Spotify, Fountain, Overcast, Podcast Addict, Pocket Casts, Castbox, Google Podcasts, Amazon Music, or on your favorite podcast platform.
In this episode, Eric Balchunas, senior ETF Analyst at Bloomberg Intelligence, discussed the performance of Bitcoin ETFs since their launch two months ago.
Balchunas noted that the ETFs' performance exceeded his expectations, with a faster and more intense "second wind" than anticipated. He attributed this to a combination of asset managers buying in, retail interest, and the "ETF effect" where the knowledge of incoming flows encourages non-ETF investors to buy.
Balchunas also predicted that BlackRock's Bitcoin ETF would likely be the most successful of the nine new spot Bitcoin ETFs, while also doubting that any of the smaller issuers would bow out.
He also discussed the potential for spot Ether ETFs, but was less optimistic about their success compared to Bitcoin ETFs.
Learn more: Bitcoin ETFs Explained: What Are They & How Do They Work?
Show highlights |
Thank you to our sponsors! iTrustCapital | Polkadot | Uniswap
Guest |
Eric Balchunas, Senior ETF analyst at Bloomberg Intelligence
Previous appearances on Unchained:
Why Spot Bitcoin ETFs Are Likely to Finally Start Trading on Thursday
Will a Spot Bitcoin ETF Finally Get Approved?
Links |
Recent coverage on Unchained of Bitcoin’s surge:
How the Bitcoins in Your ETF Get Sourced: The Real Story
Should You Sell Bitcoin Now That It’s Nearing Its All-Time High?
Miners Appear to Sell $69 Million Worth of Decade-Old Bitcoin
Bitcoin Hits New All-Time High Above $69,000, Presaging More Potential Gains
Previous coverage on the Unchained podcast of spot Bitcoin ETFs:
Bitcoin’s Price Is Way Up. And $48 Trillion in Wealth Just Got Access
Why Some Brokerage Firms Are Blocking Access to Spot Bitcoin ETFs
Why the SEC May Want Cash Creation of Spot Bitcoin ETFs
Why It Looks Like BlackRock Could Win America’s First Spot Bitcoin ETF
The 4 Factors That Will Determine Which Spot Bitcoin ETFs Win Market Share
How Much Money Will Flow Into Bitcoin ETFs? Here’s One Projection
Eric’s tweet on $IBITsmashing $788m
Ethereum spot ETF:
BitMEX Blog: Ethereum ETFs & Staking
Eric’s tweet on ether ETFs
Unchained:
Why Spot Ether ETFs Likely Won’t Steal Bitcoin’s Thunder — Even if Staking Is Included
Spot Ether ETFs Could Introduce New Concentration Risk in Ethereum: S&P Global
-
Unchained Podcast is Produced by Laura Shin Media, LLC. Distributed by CoinDesk. Senior Producer is Michele Musso and Executive Producer is Jared Schwartz.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Averill Curdy
Every day, across the planet, blood and plasma donations save human lives. Yet as with virtually all medical innovations, the story of blood donation has a dark side. In tonight's episode, Ben, Matt and Noel dive into the disturbing tale of a conspiracy spanning decades -- how an Arkansas prison profited from selling tainted inmate blood across the world, infecting an unknown number of people with insidious diseases. Yet there's a protagonist to this twisted narrative: it's also the story Kelly Duda, the courageous investigative journalist who spoke truth to power and brought this injustice to the public eye.
See omnystudio.com/listener for privacy information.
array(3) { [0]=> string(150) "https://www.omnycontent.com/d/programs/e73c998e-6e60-432f-8610-ae210140c5b1/2e824128-fbd5-4c9e-9a57-ae2f0056b0c4/image.jpg?t=1749831085&size=Large" [1]=> string(10) "image/jpeg" [2]=> int(0) }